Component
All-trans-lycopene / all-E-lycopene
All-trans-lycopene / all-E-lycopene. Species, exposure and limitations are retained in each linked claim.
11 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Lycopene-fed ferrets accumulated cis isomers and detectable apo-10-prime-lycopenol in lung tissue.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"}
- experimental_model
- Recombinant ferret enzyme and tissue-fraction metabolism
- exposure
- 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH
- limitations
- Ferret experiments do not quantify human cleavage flux or predict supplement response.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Ferret
- plain_language
- The animal experiment detected a downstream metabolite as well as intact lycopene.
- primary_references
- [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
- tissue_or_cell_type
- BCO2 enzyme; hepatic fractions and lung
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 364–375
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant ferret enzyme and tissue-fraction metabolism · source_derived_draft · unverified_draft
### lycopene-ferret-lung-metabolite Lycopene-fed ferrets accumulated cis isomers and detectable apo-10-prime-lycopenol in lung tissue. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The animal experiment detected a downstream metabolite as well as intact lycopene. organism: Ferret tissue_or_cell_type: BCO2 enzyme; hepatic fractions and lung experimental_model: Recombinant ferret enzyme and tissue-fraction metabolism limitations: Ferret experiments do not quantify human cleavage flux or predict supplement response. exposure: 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH evidence_span: {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"} [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
Complete structured claim and evidenceAll-trans tracer half-life was 5.3 ± 0.3 days versus 8.8 ± 0.6 days for cis isomers.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"}
- experimental_model
- Stable-isotope tracer and seven-compartment kinetic modeling
- exposure
- 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis
- limitations
- Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, eight healthy adults
- plain_language
- Different forms remain in circulation for different lengths of time.
- primary_references
- [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
- tissue_or_cell_type
- Plasma over 28 days and modeled tissue pools
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 234–245
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer and seven-compartment kinetic modeling · source_derived_draft · unverified_draft
### lycopene-isomer-half-life All-trans tracer half-life was 5.3 ± 0.3 days versus 8.8 ± 0.6 days for cis isomers. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Different forms remain in circulation for different lengths of time. organism: Human, eight healthy adults tissue_or_cell_type: Plasma over 28 days and modeled tissue pools experimental_model: Stable-isotope tracer and seven-compartment kinetic modeling limitations: Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons. exposure: 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis evidence_span: {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"} [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
Complete structured claim and evidence
What acts on it
All-trans lycopene was not cleaved by ferret BCO2 under the reported conditions.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"}
- experimental_model
- Recombinant ferret enzyme and tissue-fraction metabolism
- exposure
- 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH
- limitations
- Ferret experiments do not quantify human cleavage flux or predict supplement response.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Ferret
- plain_language
- The straight form did not behave like the cis forms in this enzyme assay.
- primary_references
- [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
- tissue_or_cell_type
- BCO2 enzyme; hepatic fractions and lung
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 312–323
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant ferret enzyme and tissue-fraction metabolism · source_derived_draft · unverified_draft
### lycopene-bco2-trans-null All-trans lycopene was not cleaved by ferret BCO2 under the reported conditions. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The straight form did not behave like the cis forms in this enzyme assay. organism: Ferret tissue_or_cell_type: BCO2 enzyme; hepatic fractions and lung experimental_model: Recombinant ferret enzyme and tissue-fraction metabolism limitations: Ferret experiments do not quantify human cleavage flux or predict supplement response. exposure: 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH evidence_span: {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"} [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
Complete structured claim and evidence
Where it participates (unsigned role)
Caco-2 uptake of cis lycopene exceeded all-trans uptake after simulated gac-meal digestion.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18287353.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1", "start_char": 0, "end_char": 1542, "text_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1"}
- experimental_model
- Simulated digestion followed by Caco-2 uptake
- exposure
- Gac aril or oil cooked with rice; isomer-specific measurements
- limitations
- Food matrix and cell model; not a human fractional-absorption comparison.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Cell-free digestion and human Caco-2 cells
- plain_language
- Better delivery to cultured intestinal cells is not automatically better whole-body absorption.
- primary_references
- [lycopene-p18287353] In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. (2008). https://pubmed.ncbi.nlm.nih.gov/18287353/ DOI: 10.1093/jn/138.3.482
- tissue_or_cell_type
- Cooked gac meals; mixed micelles and enterocyte model
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 156–167
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Simulated digestion followed by Caco-2 uptake · source_derived_draft · unverified_draft
### lycopene-cis-caco Caco-2 uptake of cis lycopene exceeded all-trans uptake after simulated gac-meal digestion. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Better delivery to cultured intestinal cells is not automatically better whole-body absorption. organism: Cell-free digestion and human Caco-2 cells tissue_or_cell_type: Cooked gac meals; mixed micelles and enterocyte model experimental_model: Simulated digestion followed by Caco-2 uptake limitations: Food matrix and cell model; not a human fractional-absorption comparison. exposure: Gac aril or oil cooked with rice; isomer-specific measurements evidence_span: {"source_cache": "artifacts/lycopene-research/18287353.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1", "start_char": 0, "end_char": 1542, "text_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1"} [lycopene-p18287353] In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. (2008). https://pubmed.ncbi.nlm.nih.gov/18287353/ DOI: 10.1093/jn/138.3.482
Complete structured claim and evidenceCis lycopene isomers entered mixed micelles more efficiently than all-trans lycopene during simulated digestion.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18287353.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1", "start_char": 0, "end_char": 1542, "text_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1"}
- experimental_model
- Simulated digestion followed by Caco-2 uptake
- exposure
- Gac aril or oil cooked with rice; isomer-specific measurements
- limitations
- Food matrix and cell model; not a human fractional-absorption comparison.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Cell-free digestion and human Caco-2 cells
- plain_language
- The bent forms reached the digestible micelle fraction more readily in this meal model.
- primary_references
- [lycopene-p18287353] In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. (2008). https://pubmed.ncbi.nlm.nih.gov/18287353/ DOI: 10.1093/jn/138.3.482
- tissue_or_cell_type
- Cooked gac meals; mixed micelles and enterocyte model
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 143–154
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Simulated digestion followed by Caco-2 uptake · source_derived_draft · unverified_draft
### lycopene-cis-micelles Cis lycopene isomers entered mixed micelles more efficiently than all-trans lycopene during simulated digestion. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The bent forms reached the digestible micelle fraction more readily in this meal model. organism: Cell-free digestion and human Caco-2 cells tissue_or_cell_type: Cooked gac meals; mixed micelles and enterocyte model experimental_model: Simulated digestion followed by Caco-2 uptake limitations: Food matrix and cell model; not a human fractional-absorption comparison. exposure: Gac aril or oil cooked with rice; isomer-specific measurements evidence_span: {"source_cache": "artifacts/lycopene-research/18287353.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1", "start_char": 0, "end_char": 1542, "text_sha256": "55379407d287c9a3c0057c1b7be3834f11e0349aed2821085aa0ef0e1a587ac1"} [lycopene-p18287353] In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. (2008). https://pubmed.ncbi.nlm.nih.gov/18287353/ DOI: 10.1093/jn/138.3.482
Complete structured claim and evidenceModeled bioavailability did not differ between cis lycopene, 24.5% ± 6%, and all-trans lycopene, 23.2% ± 8%.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"}
- experimental_model
- Stable-isotope tracer and seven-compartment kinetic modeling
- exposure
- 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis
- limitations
- Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, eight healthy adults
- plain_language
- Cis forms were not universally better absorbed under these conditions.
- primary_references
- [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
- tissue_or_cell_type
- Plasma over 28 days and modeled tissue pools
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 208–219
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer and seven-compartment kinetic modeling · source_derived_draft · unverified_draft
### lycopene-isomer-absorption-null Modeled bioavailability did not differ between cis lycopene, 24.5% ± 6%, and all-trans lycopene, 23.2% ± 8%. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Cis forms were not universally better absorbed under these conditions. organism: Human, eight healthy adults tissue_or_cell_type: Plasma over 28 days and modeled tissue pools experimental_model: Stable-isotope tracer and seven-compartment kinetic modeling limitations: Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons. exposure: 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis evidence_span: {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"} [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
Complete structured claim and evidenceIntestinal SR-BI-overexpressing mice had approximately tenfold higher plasma lycopene than wild-type controls.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"}
- experimental_model
- Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice
- exposure
- All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month
- limitations
- Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Mouse
- plain_language
- Changing the uptake machinery changed blood exposure in mice.
- primary_references
- [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
- tissue_or_cell_type
- Intestinal epithelium and plasma
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 130–141
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice · source_derived_draft · unverified_draft
### lycopene-mouse-srbi Intestinal SR-BI-overexpressing mice had approximately tenfold higher plasma lycopene than wild-type controls. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Changing the uptake machinery changed blood exposure in mice. organism: Mouse tissue_or_cell_type: Intestinal epithelium and plasma experimental_model: Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice limitations: Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial. exposure: All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month evidence_span: {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"} [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
Complete structured claim and evidenceNPC1L1 antibody and ezetimibe did not significantly reduce all-E or 5Z lycopene uptake in Caco-2 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"}
- experimental_model
- Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice
- exposure
- All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month
- limitations
- Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human Caco-2 cells
- plain_language
- A transporter used by other lipids was not necessary in this particular assay.
- primary_references
- [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
- tissue_or_cell_type
- Intestinal epithelium and plasma
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 117–128
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice · source_derived_draft · unverified_draft
### lycopene-npc1l1-null NPC1L1 antibody and ezetimibe did not significantly reduce all-E or 5Z lycopene uptake in Caco-2 cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A transporter used by other lipids was not necessary in this particular assay. organism: Human Caco-2 cells tissue_or_cell_type: Intestinal epithelium and plasma experimental_model: Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice limitations: Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial. exposure: All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month evidence_span: {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"} [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
Complete structured claim and evidenceModeled endogenous trans-to-cis conversion, 0.97 ± 0.25 micromol/day in the fast-turnover pool, explained cis enrichment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"}
- experimental_model
- Stable-isotope tracer and seven-compartment kinetic modeling
- exposure
- 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis
- limitations
- Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, eight healthy adults
- plain_language
- The body can change lycopene shape after absorption.
- primary_references
- [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
- tissue_or_cell_type
- Plasma over 28 days and modeled tissue pools
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 221–232
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer and seven-compartment kinetic modeling · source_derived_draft · unverified_draft
### lycopene-postabsorptive-isomerization Modeled endogenous trans-to-cis conversion, 0.97 ± 0.25 micromol/day in the fast-turnover pool, explained cis enrichment. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The body can change lycopene shape after absorption. organism: Human, eight healthy adults tissue_or_cell_type: Plasma over 28 days and modeled tissue pools experimental_model: Stable-isotope tracer and seven-compartment kinetic modeling limitations: Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons. exposure: 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis evidence_span: {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"} [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
Complete structured claim and evidenceSR-BI antibody or BLT1 inhibited all-E and 5Z lycopene uptake by up to 60% in Caco-2 monolayers.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"}
- experimental_model
- Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice
- exposure
- All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month
- limitations
- Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human Caco-2 cells
- plain_language
- One intestinal lipid transporter helps lycopene enter these cells.
- primary_references
- [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
- tissue_or_cell_type
- Intestinal epithelium and plasma
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 104–115
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice · source_derived_draft · unverified_draft
### lycopene-srbi-uptake SR-BI antibody or BLT1 inhibited all-E and 5Z lycopene uptake by up to 60% in Caco-2 monolayers. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: One intestinal lipid transporter helps lycopene enter these cells. organism: Human Caco-2 cells tissue_or_cell_type: Intestinal epithelium and plasma experimental_model: Transporter inhibition in Caco-2 cells; intestinal SR-BI transgenic mice limitations: Partial uptake inhibition is not proof of a sole transporter. Ezetimibe result is a cell assay, not a clinical drug-interaction trial. exposure: All-E and 5Z lycopene; mice received 0.25 g/kg diet for one month evidence_span: {"source_cache": "artifacts/lycopene-research/18641187.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d", "start_char": 0, "end_char": 1557, "text_sha256": "7c71fd4fd3be9d14176bceb3c2104143269a788587feec232350a6f1c5913e3d"} [lycopene-p18641187] Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1. (2008). https://pubmed.ncbi.nlm.nih.gov/18641187/ DOI: 10.1093/jn/138.8.1432
Complete structured claim and evidenceMean fractional lycopene absorption was 23% ± 6% in the human carbon-13 tracer experiment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"}
- experimental_model
- Stable-isotope tracer and seven-compartment kinetic modeling
- exposure
- 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis
- limitations
- Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, eight healthy adults
- plain_language
- Only part of an oral dose reached the body in this study.
- primary_references
- [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
- tissue_or_cell_type
- Plasma over 28 days and modeled tissue pools
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 195–206
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer and seven-compartment kinetic modeling · source_derived_draft · unverified_draft
### lycopene-tracer-absorption Mean fractional lycopene absorption was 23% ± 6% in the human carbon-13 tracer experiment. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Only part of an oral dose reached the body in this study. organism: Human, eight healthy adults tissue_or_cell_type: Plasma over 28 days and modeled tissue pools experimental_model: Stable-isotope tracer and seven-compartment kinetic modeling limitations: Small study; model-dependent pool estimates; formulation differs from food-matrix comparisons. exposure: 10.2 mg carbon-13 lycopene, 82% all-trans and 18% cis evidence_span: {"source_cache": "artifacts/lycopene-research/26561629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682", "start_char": 0, "end_char": 2207, "text_sha256": "fdc01c055cd2de5fc7523b3a3f4486ea939d5d197aaf214000328194f9586682"} [lycopene-p26561629] Compartmental and noncompartmental modeling of ¹³C-lycopene absorption, isomerization, and distribution kinetics in healthy adults. (2015). https://pubmed.ncbi.nlm.nih.gov/26561629/ DOI: 10.3945/ajcn.114.103143
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.